Pacific Cancer Institute of Maui is a clinical research site located in Wailuku, Hawaii, United States 96793.
Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.
Pacific Cancer Institute of Maui has participated in 26 clinical trials with 9 currently active.
Therapeutic areas: Neck Squamous Cell Carcinoma of Unknown Primary, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma.
Sponsors: National Cancer Institute (NCI), GOG Foundation, ECOG-ACRIN Cancer Research Group.
Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Pacific Cancer Institute of Maui has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Pacific Cancer Institute of Maui has 26 clinical trials on record, with 9 currently active. Their work covers Neck Squamous Cell Carcinoma of Unknown Primary, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma.
Yes — Pacific Cancer Institute of Maui holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.